Back

Risk of heart failure after cancer diagnosis in CHD - patients

15 April 2024 (16:54 - 17:00)
Organised by: Logo
Seminar Presentation Part of: Session 4: Top 5 Abstract Oral Presentations Adult Congenital Heart Disease (ACHD) Open Access EuroACHD 2024 WG on Adult Congenital Heart Disease

About the speaker

Photo
Doctor Christina Karazisi

Sahlgrenska University Hospital, Gothenburg (Sweden)

4 More presentations in this session

Presentation thumbnail
A validated mortality score for adults with a Fontan circulation: Fontan Adult Brompton (FAB) score
Doctor A. Arvanitaki (Thessaloniki, GR)
Slides
Presentation thumbnail
Single center experience in treatment of adults with Fontan circulation using Sodium Glucose Cotransporter-2 inhibitors
Doctor P. Skorek (Krakow, PL)
Slides
Presentation thumbnail
Safety and efficacy of DAPAGLIFLOZIN in patients with systemic right ventricular dysfunction: Preliminary results
Doctor M. Albertini (Paris, FR)
Slides
Presentation thumbnail
A review of more than 2 decades of Heart Lung Transplants at The Freeman Hospital
Doctor A. Henry (Johor Bahru, MY)
Slides

Access the full session

Session thumbnail
Session 4: Top 5 Abstract Oral Presentations

The Event

Event poster

EuroACHD 2024

15 April 2024 16:54 CET
You may be interested in
thumbnail
Congress Presentation
Cancer risks in heart failure patients: Insights from ischemic and non-ischemic cardiomyopathy
21 June 2025
thumbnail
Congress Session
Top tips in managing heart failure in adult congenital heart disease
26 August 2023
thumbnail
Webinar
Cardiac emergencies in cardio-oncology
12 April 2022
thumbnail
Congress Presentation
Quality of care, inequalities of treatment, and clinical outcomes in cancer patients presenting with acute heart failure
9 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources